|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 283, Issue 23, 16147-16161, June 6, 2008
The Synthesis of UDP-N-acetylglucosamine Is Essential for Bloodstream Form Trypanosoma brucei in Vitro and in Vivo and UDP-N-acetylglucosamine Starvation Reveals a Hierarchy in Parasite Protein Glycosylation*
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Sugar nucleotides are activated forms of sugars that are used as the ultimate source of sugar for the majority of glycosylation reactions. Sugar nucleotides are formed in two main ways: by a salvage pathway, involving activation of the sugar using a kinase and a pyrophosphorylase, or by a de novo pathway involving the bioconversion of an existing sugar/sugar nucleotide. In most cases, sugar nucleotides are synthesized in the cytoplasm and used there and/or transported through specific transporters into the lumen of the Golgi apparatus and/or endoplasmic reticulum (ER), where they are used by glycosyltransferases as donor substrates in glycosylation reactions (20, 21).
The sugar nucleotide UDP-GlcNAc is predicted to be an important metabolite in the trypanosomatid parasites, since GlcNAc is present in glycoprotein N-linked glycans in all species and in O-linked glycans in T. cruzi (22, 23), and GlcN, derived from GlcNAc by de-N-acetylation (24), is present in all species in protein-linked and free GPI structures. In T. brucei, GlcNAc is also found in N-acetyllactosamine (LacNAc) repeats of Galβ1-4GlcNAc. These LacNAc structures are found in conventional complex N-linked glycans (25) and as part of giant poly-LacNAc-containing N-linked glycans throughout the flagellar pocket and endosomal/lysosomal system of the bloodstream form (26, 27) and as side chains of the procyclin GPI anchor and free GPIs in the procyclic form of the organism (15, 28, 29). The ability to biosynthetically radiolabel T. brucei glycoproteins with [3H]GlcN (30, 31) shows that a salvage pathway exists, presumably via the action of hexokinase (GlcN
GlcN 6-phosphate). However, most likely, the de novo pathway from glucose is the most important in vivo, since free GlcN is not an abundant sugar in either mammals or insects, and its N-acetyl derivative (GlcNAc) is not taken up by T. brucei (32).
In this work, we demonstrate that the putative T. brucei uridine-acetylglucosamine pyrophosphorylase gene (TbUAP) encodes a functional enzyme (EC 2.7.7.2 [EC] 3) and, by making a bloodstream form T. brucei TbUAP conditional null mutant, demonstrate that TbUAP is essential in vitro and in vivo. We also characterize the effects of UDP-GlcNAc starvation on parasite protein glycosylation and uncover a hierarchy in protein N-glycosylation in T. brucei.
| EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
2 x 106 cells/ml at 37 °C with 5% CO2. Cloning and Sequencing of TbUAP—The TbUAP open reading frame identified in the T. brucei genome data base was amplified by PCR from genomic DNA with Pfu polymerase using forward and reverse primers containing BamHI sites (underlined) of 5'-cgcggatccaatgagtgacagggacgtgtg-3' and 5'-cgcggatccttacatgttcgatgattcgg-3', respectively. The products of six separate PCRs were cloned into pCR-BluntII-Topo®, and a representative clone from each PCR was sequenced. The primer 5'-cgcagcggttcttcgaggagaattcctac-3' was also used to obtain complete sequence coverage of the ORF.
Reverse Transcription-PCR—RNA was extracted using the RNeasy extraction kits with on-column DNase digestion (RNase-free DNase; Qiagen). RNA samples (50 ng) were treated with Ominiscript reverse transcriptase (Qiagen) to generate cDNA. The cDNAs were then amplified by PCR using Taq polymerase and TbUAP ORF primers (forward, 5'-aatgagtgacagggacgtgtg-3'; reverse, 5'-ttacatgttcgatgattcgg-3') and DPMS (Dol-P-Man synthetase) primers (forward, 5'-aatggatgcggaccttcagcacccac-3'; reverse, 5'-tagaaccgtgagcgcggtgccatac-3') to show equal RNA addition.
Southern Blotting—Genomic DNA (5 µg) was digested with appropriate restriction endonucleases. A DNA probe was made using the TbUAP ORF and the random primer labeling kit (GE Healthcare). The probe was then detected using the CDP-StarTM detection kit (GE Healthcare).
TbUAP Protein Expression and Purification—The TbUAP ORF was cloned into the BamHI site of the expression vector pET15b (Novagen) to create pET15b-TbUAP, which incorporated a His6 tag when expressed. Expression was performed using BL21 (DE3) Escherichia coli. The cells were grown overnight at room temperature with 0.05 mM isopropyl β-D-1-thiogalactopyranoside. Cells were harvested and washed in 50 mM Tris-HCl, pH 8.0, 0.3 M NaCl, 1 mg/ml lysozyme, and Roche complete protease inhibitor mixture tablets (Roche Applied Science) and then lysed in a French press. The lysate was cleared by centrifugation (40,000 x g, 60 min, 4 °C), passed through a 0.2-µm filter, and loaded onto a precharged Ni2+ HiTrapTM chelating HP column (GE Healthcare). TbUAP-His6 was eluted with 50 mM Tris-HCl (pH 8.0), 0.3 M NaCl with 0.1-0.2 M imidazole. The protein was then dialyzed overnight using a Slide-A-Lyser® dialysis cassette (Pierce) with 10 kDa molecular mass cut-off at 4 °C in 25 mM Na2HPO4-NaH2PO4 buffer, pH 8.0. The sample was then filtered as above before being loaded onto a HiTrapTM Q HP-Sepharose column (Amersham Biosciences), preequilibrated with 25 mM Na2HPO4-NaH2PO4, pH 8.0. The column was washed with 25 mM Na2HPO4-NaH2PO4, pH 8.0, followed by a gradient to 25 mM Na2HPO4-NaH2PO4, pH 8.0, 0.5 M NaCl over 30 min. Fractions (3 ml) were collected and checked by SDS-PAGE. TbUAP-His6-containing fractions were pooled and concentrated, and the buffer was exchanged to 50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, and 20% glycerol using a Vivaspin concentrator (Vivascience) 10 kDa molecular mass cut off at 4 °C. The protein was then stored at -80%.
To obtain a PreScission protease cleavable His6-tagged TbUAP protein, the TbUAP open reading frame was amplified by PCR from the aforementioned pET15b-TbUAP plasmid using the forward primer, 5'-ctccatgggcagcagccatcatcatcatcatcacagcagcggcctggaagttctgttccaggggcccggatccATGAGTGACAGGGACGTGTGCATTCAG-3', containing an NcoI restriction site (underlined), the coding sequences for MGSSHHHHHHSSG (italic type), and a PreScission protease cleavage site of LEVLFQGP (boldface type), followed by a BamHI restriction site (underlined) and a TbUAP gene-specific sequence (uppercase) and the reverse primer, 5'-gctcgagatctggatccTTACATGTTCGATGATTCGGAGACCACC-3', containing restriction sites for BglII and BamHI (italic type) and a TbUAP gene-specific sequence (uppercase). The PCR product was cloned into the pGEM-T Easy PCR cloning vector (Promega) and subsequently digested with NcoI and BglII and inserted between the NcoI and BamHI sites of the pET15b protein expression vector (Novagen). The resulting construct, pET15b-His6-PP-TbUAP, that encodes the full TbUAP coding sequence preceded by the sequence MGSSHHHHHHSSGLEVLFQGPGS (where PreScission protease cleaves between the Q and the G) was expressed in E. coli and purified on an Ni2+ HiTrapTM chelating HP column, as described above. The sample was then digested with
2 mg of GST-PreScission protease (a kind gift of Bill Hunter; University of Dundee) in 50 mM Tris, pH 8.0, 100 mM NaCl, 10 mM EDTA, and 1 mM dithiothreitol at room temperature for 4-16 h at 4 °C. The sample was dialyzed for 2 h using a Slide-A-Lyser® dialysis cassette (10 kDa molecular mass cut-off) at 4 °C in 2 liters of 50 mM Tris-HCl, pH 8.0, and 50 mM NaCl to remove the EDTA, and then the sample was passed though a 0.2-µm syringe filter. The sample was passed through a GSTrapTM HP column (GE Healthcare) connected to an Ni2+ HiTrapTM chelating HP column. The flow-through was then dialyzed overnight using a Slide-A-Lyser® dialysis cassette at 4 °C in 1 liter of 25 mM Na2HPO4-NaH2PO4, pH 8.0, with two changes of buffer. The sample was then passed though a 0.2-µm syringe filter and further purified using anion exchange chromatography on a HiTrapTM Q HP-Sepharose column (GE Healthcare).
TbUAP Assays—Two methods were used to assay TbUAP. The HPLC assay used 0.05 µg of TbUAP-His6 incubated in 100 µl of the HPLC assay buffer (50 mM Tris-HCl, pH 7.5, 250 µM UTP, 10 mM MgCl2, 1 mM dithiothreitol, 20% glycerol, 250 µM GlcNAc-1-P) for 10 min, terminated by boiling for 5 min. The samples were analyzed using conditions based on Ref. 34. The HPLC assay buffer was altered to study substrate specificity, metal ion dependence, and pH dependence. For substrate specificity, GlcNAc-1-P was changed to glucose 1-phosphate, galactose 1-phosphate, or GalNAc-1-P, all at 250 µM. For metal ion dependence, MgCl2 was replaced with CaCl2, CuCl2, ZnCl2, or MnCl2. For pH dependence, the Tris-HCl buffer was replaced with a dual buffer of 50 mM Tris, 50 mM sodium acetate with the pH adjusted with HCl.
The TbUAP colorimetric assay was performed with 0.05 µg of TbUAP-His6 in a 96-well plate format (NuncTM) in 90 µl of 50 mM Tris-HCl, pH 7.5, 250 µM UTP, 250 µM GlcNAc-1-P, 10 mM MgCl2, 1 mM dithiothreitol, 20% glycerol, 0.04 units/ml pyrophosphatase (Sigma). The reaction was left for 10 min and terminated by the addition of 100 µl of the color reagent (0.2% ammonium molybdate, 0.5% Triton X-100, 0.7 N HCl, 0.03% malachite green). Absorbance at 655 nm was measured after 5 min using a SpectraMax 340 PC (Molecular Devices).
Construction of a TbUAP Conditional Null Mutant—The gene replacement cassettes were generated by PCR amplification of 500 bp of UTR immediately flanking the 5'- and 3'-ends of the TbUAP ORF with Taq polymerase using the forward and reverse primers 5'-aaggaaaaaaGCGGCCGCagatgcgtgcacaacaaaaa-3' and 5'-gtttaaacttacggaccgtcaagctttatctataacacacggagcc-3' and 5'-gacggtccgtaagtttaaacggatccgtggacgttgcagcgcccgg-3' and 5'-aaggaaaaaaGCGGCCGCcaccacagttcaccatccag-3, respectively. The two PCR products were then used in a separate PCR to produce a construct containing the 5'-UTR linked to the 3'-UTR by a short HindIII, PmeI, and BamHI cloning site (italic type). The resulting PCR product was then ligated into pGEM-5Zf(+) vector (Promega) using the NotI site (uppercase). Antibiotic resistance markers were cloned into the HindIII/BamHI restriction sites between the two UTRs to produce two constructs, one containing the PAC (puromycin acetyltransferase) drug resistance gene and one containing the HYG (hygromycin phosphotransferase) drug resistance gene. To generate the tetracycline-inducible ectopic copy of the TbUAP ORF, the Nde1 site in the ORF was silenced using the primers 5'-aagcttgggatagcatacgtgcagattggaa-3' and 5'-attccaatctgcacgtatgctatcccaagct-3'. The primers 5'-catatgatgagtgacagggacgtgtg-3' and 5'-ttaattaattacatgttcgatgattcgg-3' were then used to PCR-amplify the ORF, which was cloned into the vector pLew100 using the NdeI and PacI sites (italic type) (33).
These constructs were purified using the Qiagen Maxiprep kit, digested with NotI to linearize, precipitated, washed twice with 70% ethanol, and redissolved in sterile water. The linearized DNA was electroporated into T. brucei bloodstream cells (strain 427, variant 221) that were stably transformed to express T7 RNA polymerase and the tetracycline repressor protein under G418 selection. Cell culture, transformation, and selection were carried out as previously described (33).
Mouse Infection Studies—The TbUAP conditional null mutant cells were subcultured and grown without selection drugs (hygromycin, puromycin, phleomycin, and G418) for 24 h with and without 1 µg/ml tetracycline. The parasites were then introduced into groups of five mice (dosed with and without doxycycline, respectively) by intraperitoneal injection of 3 x 105 parasites in 0.2 ml of HMI-9 medium. The plus doxycycline group of animals were dosed with doxycycline in the drinking water (0.2 mg/ml in a 5% sucrose solution) for 1 week prior to infection and until the experiment was terminated. Infections were assessed by tail bleeding, diluting the blood 1:200 in HMI-9 medium and counting on a Neubauer hemocytometer.
TbUAP Localization—Two BALB/c adult mice were used to raise polyclonal antibodies against His6-tagged TbUAP protein with Freund's complete adjuvant. Each mouse received two further immunizations with Freund's incomplete adjuvant over 2 months. Antibodies were then affinity-purified on CNBr-Sepharose-immobilized TbUAP that had had its His6 tag removed with PreScission protease.
Wild type and TbUAP conditional null mutant bloodstream form T. brucei cells were grown in HMI-9 medium (with or without 1 µg/ml tetracycline for the conditional null mutant) to a density of 1 x 106 cells/ml over 48 h, harvested by centrifugation, and resuspended in trypanosome dilution buffer (0.1 M Na2HPO4, 0.01 M NaH2PO4, 0.025 M KCl, 0.4 M NaCl, 5 mM MgSO4, 0.1 M glucose adjusted to pH 7.45 with HCl) to a density of 4 x 107 cells/ml. Aliquots (15 µl) were added to 13-mm coverslips (VWR), left at room temperature for 15 min, fixed in 1 ml of 4% paraformaldehyde in phosphate-buffered saline (PBS) for 1 h followed by three 5 min washes in 2 ml of PBS. Cells were permeabilized with 0.05% Triton X-100 in PBS containing 0.5 mg/ml bovine serum albumin for 10 min at room temperature. Samples were then blocked in 2 ml of PBS, 0.5% bovine serum albumin, for 1 h at room temperature. The coverslips were incubated with mouse anti-TbUAP (1:5,000 dilution) and rabbit anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antiserum (1:10,000; a kind gift of Paul Michels, Catholic University of Louvain) in PBS, 0.5% bovine serum albumin. Samples were then washed, as above, in PBS, 0.5% bovine serum albumin and incubated with 50 µl of Alexa 594-conjugated anti-mouse IgG and Alexa 488-conjugated anti-rabbit IgG (containing 4',6-diamidino-2-phenylindole in the case of the wild type cells) for 1 h. Coverslips were mounted on glass slides (VWR), sealed with Hydromount containing 2.5% 1,4-diazabicyclo[2.2.2]octane and left to dry in the dark for 30 min. Microscopy was performed on a Zeiss Axiovert 200 M fluorescence microscope for wild type cells and on a Zeiss LSM 510 META confocal microscope for the TbUAP conditional null mutant cells.
|
Lectin and Antibody Blotting—T. brucei cells washed with trypanosome dilution buffer and hypotonically lysed in 300 µl of water containing 0.1 mM 1-chloro-3-tosylamido-7-amino-2-heptone (TLCK) and 1 µg/ml leupeptin. Cell ghosts were harvested by centrifugation (13,000 x g for 10 min), and the pellet was resuspended in SDS-sample buffer containing 8 M urea. The lysed extracts were then subjected to electrophoresis under reducing conditions, with 1.5 x 107 or 5 x 107 cell equivalents/lane, on a NuPAGE® 4-12% BisTris gradient (Invitrogen) using MOPS SDS running buffer. Proteins were then transferred to a nitrocellulose membrane under normal Western blotting conditions. Membranes were stained with Ponceau S solution to demonstrate equal loading, blocked with 0.25% bovine serum albumin, 0.05% Igepal detergent (Sigma), 0.15 M NaCl in 50 mM Tris-HCl, pH 7.4, and then incubated with 0.33 µg/ml biotinylated tomato lectin (Vector Laboratories), with or without 3 mg/ml chitin hydrolysate (Vector Laboratories), and then with 1:10,000 diluted ExtraAvidin-horseradish peroxidase conjugate (Sigma). All membranes were then developed by chemiluminescent detection (ECL-plus; GE Healthcare).
To probe for p67, T. brucei was lysed with SDS-sample buffer and loaded onto a 10% SDS-polyacrylamide gel before being transferred to nitrocellulose membrane. The membrane was then probed with MAb139 (a kind gift from Jay Bangs, Madison) at a dilution of 1:2,000 as the primary antibody and then with 1:10,000 diluted anti-mouse IgG conjugated with horseradish peroxidase, followed by ECL reagent as described above.
Purification and Endoglycosidase Digestion of Soluble Form Variant Surface Glycoprotein (sVSG)—The VSG coat of trypanosomes can be conveniently released in a soluble form through osmotic cell lysis at 37 °C. This causes cleavage of the dimyristoylglycerol component of the GPI membrane anchors by the action of an endogenous GPI-specific phospholipase C (30). T. brucei cultures (100 ml) were washed in trypanosome dilution buffer and resuspended in 300 µl of lysis buffer (10 mM NaH2PO4-Na2HPO4, pH 8.0, 0.1 mM TLCK, 1 µg/ml leupeptin, and 1 µg/ml aprotinin) and incubated at 37 °C for 10 min. This was then cooled on ice for 2 min and centrifuged for 5 min at 16,000 x g, and the supernatant was applied to 200 µl of DE52 (Whatman) preequilibrated in 10 mM NaH2PO4-Na2HPO4, pH 8.0, buffer and eluted with 4 x 200 µl of fresh lysis buffer. The eluates were pooled and concentrated to
100 µl using a YM-10 spin concentrator (Microcon). The majority of the buffer salts were removed by diafiltration with three additions of 0.5 ml of water.
For each enzyme digestion, sVSG was dissolved at 0.2 µg/µl in 0.5% SDS, 0.1 M dithiothreitol and boiled for 10 min. For endoglycosidase H (Endo H) digests, 5 µl of the sVSG was added to 20 µl of 50 mM sodium citrate, pH 5.5, 10 mM phenylmethylsulfonyl fluoride, and 0.025 units of Endo H. For N-glycosidase F (PNGase F) digests, 5 µl of sVSG was added to 50 mM sodium phosphate, pH 7.5, 0.1% Triton X-100, 10 mM phenylmethylsulfonyl fluoride, and 0.025 units of PNGase F. The digests were then left overnight at 37 °C.
Electrospray Mass Spectrometry of sVSG—Intact sVSG was diluted to 0.05 µg/µl in 50% methanol, 1% formic acid and loaded into Micromass type-F nanotips. The sVSG was analyzed by positive ion electrospray tandem mass spectrometry using an Applied Biosystems Q-StarXL instrument, and the masses were calculated using the Bayesian protein reconstruction algorithm (ABI Analyst Software).
| RESULTS |
|---|
|
|
|---|
The TbUAP ORF was cloned into a pET15b expression vector, with a His6 tag at the N terminus and a modified pET15b vector with a PreScission protease site between the protein and the His6 tag. Both were expressed in E. coli and purified as described under "Experimental Procedures" (supplemental Figs. 3 and 4). Analysis of the recombinant TbUAP-His6 protein by analytical ultracentrifugation (at 1 mg/ml) indicated that the majority (>80%) of TbUAP is monomeric at this concentration (data not shown).
Enzymatic Activity of TbUAP—The activity and substrate specificity of TbUAP was assessed by incubating recombinant TbUAP-His6 with UTP and GlcNAc-1-P, GalNAc-1-P, Glc 1-phosphate, or Gal 1-phosphate and analyzing the products by HPLC. Using GlcNAc-1-P as the substrate, a single UV-absorbing peak that co-eluted with authentic UDP-GlcNAc was observed (Fig. 1A). No sugar nucleotide product was observed in the absence of TbUAP-His6 (Fig. 1B) or when GalNAc-1-P, Glc 1-phosphate, or Gal 1-phosphate was used as a substrate (Fig. 1, C-E). These data show that GlcNAc-1-P is the preferred substrate of TbUAP under these conditions.
To test the metal ion dependence of the TbUAP-His6 activity, the enzyme was preincubated with 5 mM EDTA and then incubated with UTP, GlcNAc-1-P, and 10 mM MgCl2, MnCl2, CaCl2, CuCl2, ZnCl2, or no divalent cation. The products of triplicate experiments were analyzed by HPLC, and relative yields of UDP-GlcNAc were determined. In the presence of EDTA alone, no detectable UDP-GlcNAc was formed, suggesting that TbUAP is divalent metal ion-dependent. Similar levels of activity were restored with Mg2+ and Mn2+, whereas Ca2+, Cu2+, and Zn2+ failed to restore detectable activity (supplemental Fig. 5).
The pH dependence of the activity was studied over the pH range 5.0-9.5, using the same HPLC-based assay. The enzyme displayed a broad pH optimum between pH 6.0 and 9.0 (supplemental Fig. 6). Based on the aforementioned experiments, the enzyme was assayed at pH 7.5 in the presence of 10 mM MgCl2.
In order to measure the apparent Km values for the two substrates of TbUAP, a discontinuous, colorimetric, coupled assay was employed. The assay relies on pyrophosphatase to convert the PPi component of the UTP + GlcNAc-1-P
UDP-GlcNAc + PPi reaction to inorganic phosphate, which is subsequently measured using malachite green. The enzyme was assayed with a fixed concentration of UTP and varying concentrations of GlcNAc-1-P and with a fixed concentration of GlcNAc-1-P and varying concentrations of UTP (supplemental Figs. 7 and 8). The apparent Km values for UTP and GlcNAc-1-P are 26 ± 6 and 39 ± 13 µM, respectively, with a Vmax of 0.4 ± 0.1 nmol/min and a specific activity of 24 ± 6 µmol/min/mg. These values are compared with those of other recombinant eukaryotic UAPs (36-38) in Table 1.
|
|
TbUAP:PAC clone was selected and transformed with an ectopic, tetracycline-inducible, copy of TbUAP, introduced into the ribosomal DNA locus under phleomycin selection (33). After tetracycline induction, the second endogenous allele was replaced by a HYG gene to yield the desired
TbUAP:PAC/TbUAPTi/
TbUAP: HYG clone (Fig. 2A). After each round of transformation, genomic DNA was extracted for Southern blot analysis using a TbUAP ORF probe and genomic DNA digested with BglII and NheI. Under these conditions, the endogenous TbUAP gene produces a fragment of
5.6 kb, whereas the ectopic copy produces a fragment of
2.5 kb. The blot (Fig. 2B) shows the successful introduction of the ectopic copy and replacement of both endogenous alleles in the
TbUAP:PAC/TbUA-PTi/
TbUAP:HYG clone used for further studies. This cell line will be referred to from hereon as the TbUAP conditional null mutant. The TbUAP Gene Is Essential to Bloodstream Form T. brucei in Vitro and in Vivo—Triplicate cultures of wild type and TbUAP conditional null mutant cells, under permissive and nonpermissive conditions (i.e. with and without tetracycline, respectively), were inoculated at 1 x 105 cells/ml and subcultured every 2 days. The TbUAP conditional null mutant cultures under permissive conditions had a reduced growth rate and grew to approximately half the cell density of the wild type but were otherwise healthy (Fig. 3, A and B). Under nonpermissive conditions the cells grew for 2 days but, upon subculturing, failed to grow for more than 5 days (Fig. 3C). The eventual resumption of growth is typical of bloodstream form T. brucei conditional null mutants for essential genes (6, 14, 18, 39-42), whereby the essential gene becomes constitutively active through loss of tetracycline control due to deletion of the tetracycline repressor protein gene (14). Analysis by reverse transcription-PCR confirmed that TbUAP mRNA was undetectable by 12 h of tetracycline removal but that the cells that resumed growth, 10 days after tetracycline removal, were reexpressing TbUAP mRNA (Fig. 3D).
|
Subcellular Localization of TbUAP—To obtain antibodies, TbUAP-His6 was used to inoculate mice and the resulting anti-serum was affinity-purified on a column of recombinant PreScission protease-treated (tag-free) TbUAP coupled to CNBr-Sepharose beads. The mouse anti-TbUAP affinity-purified antibody was used together with rabbit anti-GAPDH antibody as a glycosomal marker. The secondary antibodies were anti-mouse Alexa 594 (red) and anti-rabbit Alexa 488 (green). The fluorescence micrographs of wild type cells show that the anti-GAPDH co-localized with the anti-TbUAP, indicating that TbUAP is located in glycosome microbodies in bloodstream form T. brucei (Fig. 4, A-C). A similar experiment was performed with the TbUAP conditional null mutant grown with and without tetracycline for 48 h. The results show that the TbUAP signal co-localizes with the glyosomal GAPDH marker (as before) (Fig. 4, D-F) but that the intensity of the TbUAP signal is greatly reduced after 48 h without tretracycline (Fig. 4, G-I), demonstrating the strict specificity of the antibody for TbUAP in immunofluorescence microscopy.
Sugar Nucleotide Levels in the TbUAP Conditional Null Mutant—To analyze the effect of the selective removal of TbUAP gene expression on parasite UDP-GlcNAc levels, sugar nucleotides were extracted from the TbUAP conditional null mutant under permissive and nonpermissive conditions, chromatographed as described in (35), and quantitated by the method described in Ref. 19. Briefly, sugar nucleotides were extracted from T. brucei, separated by reverse phase HPLC and quantitated by multiple reaction monitoring tandem mass spectrometry using an internal standard (GDP-glucose), a sugar nucleotide that is not found in trypanosomes. The multiple reaction monitoring approach exploits characteristic transitions between precursor and product ions to identify specific metabolites in complex mixtures. For example UDP-GlcNAc gives rise to an [M-H]- precursor ion at m/z 606 that fragments to produce a major product ion of [UDP-H2O]- at m/z 385. Thus, a chromatogram of the mass transition 606
385 is highly selective for UDP-GlcNAc. Similarly, GDP-Man and GDP-Glc can be monitored using the [GDP-Hex]- to [GDP-H2 O]- transition of m/z 604
424. Representative chromatograms (Fig. 5) illustrate the dramatic reduction in UDP-GlcNAc levels, relative to the GDP-Glc internal standard, in the TbUAP conditional null mutant after 48 h in the absence of tetracycline. These data and the effects on other sugar nucleotides are summarized in (Table 2). The levels of UDP-Glc, UDP-Gal, and GDP-Man in the TbUAP conditional null cell line under permissive conditions agree reasonably well with the wild type levels determined previously (19). However, even under permissive conditions, the level of UDP-GlcNAc is significantly lower in the conditional null mutant (16 pmol/1 x 107 cells) than in the wild type (80 pmol/1 x 107 cells). The reduced level may be because TbUAP expression is no longer under the control of its endogenous promoter but rather under the control of the procyclin promoter in the pLew100-TbUAP ectopic copy. Thus, the lower growth rate of the mutant under permissive conditions may be a result of the reduced level of UDP-GlcNAc. Under nonpermissive conditions, the cells stopped dividing between 48 and 60 h and died, by cell lysis, by around 72 h. At 48 h, the level of UDP-GlcNAc was 2.9 pmol/1 x 107, <5% of wild type levels.
|
|
Effects of UDP-GlcNAc Starvation on Protein Glycosylation—Ricin, which binds nonreducing terminal galactose residues, has been shown to bind to the flagellar pocket of T. brucei (43) and to the endosomal/lysosomal system of the parasite (27). The poly-N-acetyllactosamine-specific (Galβ1-4GlcNAc), lectin from Lycopersicon esculentum (tomato) has also been shown to bind exclusively to glycoproteins in the flagellar pocket and endosomal/lysosomal system in T. brucei (26). The ricin and tomato lectin binding oligosaccharide structures were characterized and were shown to include a family of unusually large N-linked poly-N-acetyllactosamine-containing glycans with an average of 54 N-acetyllactosamine repeats/glycan (27).
The effect of UDP-GlcNAc starvation on these structures was assessed using Western blots of whole cell lysates from wild type and the TbUAP conditional null mutant cell lines probed with tomato lectin. A large smear was detected in the wild type cell lysate, which decreased progressively from 0 to 48 h in the absence of tetracycline in the TbUAP conditional null mutant (Fig. 6A). The decrease in intensity, and a downward shift in apparent molecular weight, of the tomato lectin binding high molecular weight glycoproteins indicated a reduction in total poly-N-acetyllactosamine synthesis as the cellular levels of UDP-GlcNAc fall. The specificity of the tomato lectin blot for carbohydrate was confirmed by including chitin hydrolysate, a tomato lectin inhibitor (Fig. 6B). To distinguish whether this reduction in tomato lectin binding was specifically caused by UDP-GlcNAc starvation and not just a general phenomenon in dying cells, the same experiment was performed with a TbGPI12 conditional null mutant (6). This is another (lethal) glycosylation conditional null mutant but, this time, in the GPI biosynthetic pathway. Under nonpermissive (without tetracycline) conditions, this cell line also ceases cell division and dies, but, in this case, the cell lysate blots showed relatively little change in tomato lectin binding (supplemental Fig. 9).
To observe the effects of UDP-GlcNAc starvation on a specific glycoprotein, wild type and TbUAP conditional null mutant cells, grown in the presence and absence of tetracycline for 24 and 48 h, were harvested, lysed, and analyzed by SDS-PAGE and Western blotting with the p67-specific monoclonal antibody MAb139 (supplemental Fig. 10). The intensity of the staining was slightly decreased, compared with wild type, in the TbUAP conditional null mutant under permissive conditions (0 h), which may reflect the overall difference in UDP-GlcNAc levels between the mutant and wild type cell line described earlier. After 48 h in the absence of tetracycline, both the intensity and the apparent molecular weight of the p67 smear had decreased. This result suggests that p67 glycosylation is impaired by UDP-GlcNAc starvation.
|
To assess the effects of UDP-GlcNAc starvation on gross cellular morphology and flagellar pocket morphology, including the appearance of the flagellar pocket lumenal contents, wild type cells and TbUAP conditional null mutant cells, grown in the absence of tetracycline for 48 h, were subjected to scanning and transmission electron microscopy (supplemental Figs. 11 and 12, respectively). However, no significant differences in the images were recorded.
To observe the effects UDP-GlcNAc starvation had on VSG glycosylation, sVSG was purified from wild type and TbUAP conditional null mutant cells, grown in the presence and absence of tetracycline for 48 h. Analysis by SDS-PAGE and Coomassie Blue staining revealed that sVSG from wild type and TbUAP conditional null cells grown under permissive conditions appear as single bands, whereas sVSG from the TbUAP conditional null grown for 48 h in the absence of tetracycline appeared as a doublet (Fig. 8A). The formal possibility that the altered sVSG profile may have been caused by the cells switching VSG expression to a new VSG variant was eliminated by tryptic mass fingerprinting, by which both bands were positively identified as VSG221 (data not shown).
|
To analyze this further, the sVSG samples were analyzed by electrospray mass spectrometry (Fig. 9). Wild type and TbUAP conditional null mutant cells grown under permissive conditions gave the expected glycoform mass ranges for sVSG221 (16, 44) (Table 3). However, sVSG from the TbUAP conditional null mutant grown under nonpermissive conditions for 48 h displayed two discrete sets of sVSG glycoforms, corresponding to the two bands seen by SDS-PAGE. One set was similar to that of wild type sVSG, except that it lacks the higher molecular weight glycoforms that contain five GlcNAc residues (Table 3). The other set of glycoforms have masses consistent with the absence of oligomannose structures at the C-terminal (Asn-428) N-glycosylation site (consistent with the Endo H resistance of the lower VSG band on SDS-PAGE). Analysis of the glycopeptide fraction of a Pronase digest of the mutant VSG sample, prepared and analyzed by electrospray tandem mass spectrometry according to Ref. 54, revealed a range of Asn-263 and Asn-428 N-linked glycopeptide and Ser-433 GPI glycopeptide species4 similar to those of wild type VSG (supplemental Fig. 13). These results rule out the possibility that lower molecular weight VSG glycoforms arise from changes at the N-linked and GPI glycosylation sites that happen to be equivalent in mass to the loss of the oligomannose structures from Asn-428.
|
Taken together, these data show that under UDP-GlcNAc starvation, the elaboration of the Man3GlcNAc2 and Man4GlcNAc2 glycans at the fully occupied Asn-263 N-glycosylation site glycans with GlcNAc and Galβ1-4GlcNAc is significantly reduced and that the occupancy of the C-terminal Asn-428 site is selectively and dramatically reduced.
| DISCUSSION |
|---|
|
|
|---|
Analysis of the recombinant UAP from T. brucei demonstrated that TbUAP is a conventional divalent cation-dependent pyrophosphorylase with kinetic parameters similar to those reported for other eukaryotic UAPs. However, TbUAP differs from most other UAPs in that it is highly selective for its sugar phosphate substrate, accepting only GlcNAc 1-phosphate, and that it is compartmentalized in a microbody, the glycosome.
With respect to the former, the inability of TbUAP to accept GalNAc-1-P reflects the fact that T. brucei, like all of the trypanosomatids, does not incorporate GalNAc into its glycoconjugates (reviewed in Ref. 19). Thus, the organism has no need to make UDP-GalNAc either from GalN or GalNAc or by epimerization of UDP-GlcNAc. Accordingly, both TbUAP (this study) and TbGalE (15) are exclusively GlcNAc-1-phosphate- and UDP-Glc/Gal-specific, respectively. This is unlike their mammalian counterparts that can also utilize GalNAc-1-P (36) and UDP-GlcNAc/GalNAc (48), respectively. Comparison of the TbUAP sequence with those of the human AgX1 and AgX2 UAP splice variants, for which there are crystal structures (36), indicates that TbUAP has a conserved active site, containing only a 2-amino acid difference among the 15 identified substrate-interacting residues (i.e. Arg-313 in place of Pro-288 and Ala-489 in place of Lys-455). Peneff et al. (36) reported that the equatorial GlcNAc C4 hydroxyl of UDP-GlcNAc forms one hydrogen bond with Gly-290 and one with Asn-327 of AgX1 and that the axial GalNAc C4 hydroxyl of UDP-GalNAc forms two hydrogen bonds with Asn-327. The equivalent residues in TbUAP are Gly-315 and Asn-352. However, the context of the key Asn residue (underlined) in TbUAP is KFNCANISSNLC whereas in the AgX enzymes it is LFNAGNIANHFF. Nonequivalent adjacent residues (in italic type), particularly the bulkier CA versus AG sequence immediately before the Asn residue, may affect the latter hydrogen bond network and account for the observed selectivity of TbUAP for GlcNAc-1-P over GalNAc-1-P. We are attempting to crystallize TbUAP to resolve this issue.
|
In all trypanosomatids, the two-step conversion of glucose to fructose 6-phosphate, via hexokinase and glucose-6-phosphate isomerase, occurs in the glycosome, and it is conceivable that the entire UDP-GlcNAc biosynthetic pathway is located in this organelle. Although glucosamine-fructose-6-phosphate transaminase, glucosamine-phosphate N-acetyltransferase, and phosphoacetylglucosamine mutase lack obvious PTS1 or PTS2 sequences, the T. cruzi and L. major glucosamine-6-phosphate deaminase sequences do contain PTS1 sequences (46). This enzyme catalyzes the reverse reaction to glucosamine-fructose-6-phosphate transaminase. Our current hypothesis, which we are currently testing, is that glucosamine-fructose-6-phosphate transaminase, glucosamine-phosphate N-acetyltransferase, and phosphoacetylglucosamine mutase are piggybacked into the glycosome via oligomerization with glucose-6-phosphate isomerase and/or glucosamine-6-phosphate deaminase and/or TbUAP to provide functional UDP-GlcNAc synthesis machinery in a single location. Indeed, it may be that all sugar nucleotide biosynthesis occurs in this location in trypanosomes, since both UDP-Glc 4'-epimerase and GDP-Man 4,6-dehydratase, required for in UDP-Gal and GDP-Fuc synthesis, respectively, have also been shown to be glycosomal in T. brucei (15, 18). A glycosomal location for the synthesis of sugar nucleotides further suggests that there may be specific transporters or antiporters in the glycosome membrane to, for example, exchange UTP for UDP-sugars and GTP for GDP-sugars or NDP-sugars for PPi. In this regard, it is worth noting that, whereas most sugar nucleotide antiporters exchange NDP-sugars for NMPs (50) (requiring nucleoside diphosphatases to convert NDPs to NMPs), NDP-sugar/NDP and NDP-sugar/NDP-sugar antiporter activities have also been recently reported (51).
|
|
Another way of assessing the glycosylation phenotype of bloodstream form T. brucei mutants is to use the abundant VSG as a reporter and to assess the status of its two N-glycosylation sites and GPI anchor (16, 44). In the case of UDP-Gal starvation, the copy number and integrity of the VSG coat is not affected, although the GPI anchors, which normally sport an average of five Gal side chain residues, are free of galactose (16). The effect on VSG glycosylation was very different under UDP-GlcNAc starvation. Mass spectrometry and endoglycosidase digestion of VSG221 isolated from the TbUAP conditional null mutants under nonpermissive conditions revealed the presence of two major species of VSG221 in approximately equal amounts. One form was almost indistinguishable from wild-type VSG221, whereas the other, lower molecular mass form, specifically lacked the C-terminal (Asn-428) N-linked glycan. From a hierarchical point of view, it is not surprising that GPI anchor synthesis is maintained, even when protein N-glycosylation and N-glycan elaboration are affected, since GPI synthesis and transfer to protein are clearly essential to bloodstream form T. brucei (5-8). Furthermore, from a structural point of view, the Asn-263 N-linked glycan may be more important to the correct folding of the VSG. Blum et al. (52) analyzed the crystal structures of two VSG variants, VSG ILTat.1.24 and VSG221, and found that a short
-helix in ILTat.1.2 is absent in VSG221 but replaced by the protein-proximal sugars of the Asn-263 N-linked glycan. However, this does not provide a mechanistic explanation for the hierarchy of Asn-263 N-glycosylation in strict preference to the N-glycosylation of Asn-428 under UDP-GlcNAc starvation. Radiolabeling studies suggest that bloodstream form T. brucei co